Comparison of the Accuracy of the Novel PrisMax Continuous Renal Replacement Therapy System to the Classic Prismaflex System

Comparison of the Accuracy of the Novel PrisMax Continuous Renal Replacement Therapy System to the Classic Prismaflex System

Background/Aims: We assessed how the novel PrisMax continuous renal replacement therapy (CRRT) system performed in an international multicentre setting. The system has multiple novel tools aiming to increase accuracy and dose delivery. Methods: Data was prospectively collected from 7 intensive care...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood purification 2019-01, Vol.47 (1-3), p.166-170
Hauptverfasser: Bell, Max, Broman, Marcus, Joannes-Boyau, Olivier, Ronco, Claudio
Format: Artikel
Sprache:eng
Schlagworte:
Critical Care Nephrology – Research Article
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 170
container_issue 1-3
container_start_page 166
container_title Blood purification
container_volume 47
creator Bell, Max
Broman, Marcus
Joannes-Boyau, Olivier
Ronco, Claudio
description Background/Aims: We assessed how the novel PrisMax continuous renal replacement therapy (CRRT) system performed in an international multicentre setting. The system has multiple novel tools aiming to increase accuracy and dose delivery. Methods: Data was prospectively collected from 7 intensive care units in 6 countries. The PrisMax device data logs constituted the raw material and last generation Prismaflex data was used as comparison. Clinical parameters like treatment time, filter life span, downtime as well as prescribed and delivered dose were recorded. Results: PrisMax delivered/prescribed effluent ratios (mean ± SD) 0.92 ± 0.15 vs. Prismaflex ratios 0.85 ± 0.21, p < 0.001; delivered effluent dose (mL/kg/h) was 18.16 ± 12.93 vs. 10.95 ± 10.96, p < 0.0001; and (Kt/V) 0.76 ± 0.52 vs. 0.44 ± 0.44, p < 0.0001. Moreover, downtime was 27 minutes less for the newer device. Conclusion: The PrisMax CRRT device outperforms its predecessor with regard to dose delivery and accuracy.
doi_str_mv 10.1159/000494764
format Article
fullrecord <record><control><sourceid>proquest_karge</sourceid><recordid>TN_cdi_karger_primary_494764</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2133823342</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-fbd101f6a63fd7169c2505977fb6c5c3c79d8094f6dd6b6d774ffa48c8e5737e3</originalsourceid><addsrcrecordid>eNpt0c1P1jAcB_DGYOQRPXg3pAkXPUzb9W07wuJbgkAUzk3X_SqDbR3tpjyJf7yVjefEpW_55PtL80XoDSUfKBXlR0IIL7mS_BnaUJ7TrFRM7KENyQXLBJHFPnoZ4w0hlEtRvkD7jPC84FJt0N_K96MJbfQD9g5P14CPrZ2DsdvH-5n_DR2-SOa7uceVH6Z2mP0c8Q8YTJfWsTMWehgmfHkNwYxb_HMbJ-jx5B8Cqs7E2NqHiN64Du5X8Ao9d6aL8HrdD9DV50-X1dfs9PzLt-r4NLNM5VPm6oYS6qSRzDWKytLmgohSKVdLKyyzqmwKUnInm0bWslGKO2d4YQsQiilgByhbcuMfGOdaj6HtTdhqb1q9Pt2mE2hecMpJ8u8WPwZ_N0OcdN9GC11nBkgf1zllrMgZ43mi7xdqg48xgNuFU6L_l6N35SR7uMbOdQ_NTj62kcDRAm5N-AVhB04urpYIPTYuqbdPqnXKP7mioGM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2133823342</pqid></control><display><type>article</type><title>Comparison of the Accuracy of the Novel PrisMax Continuous Renal Replacement Therapy System to the Classic Prismaflex System</title><source>Karger Journals</source><creator>Bell, Max ; Broman, Marcus ; Joannes-Boyau, Olivier ; Ronco, Claudio</creator><creatorcontrib>Bell, Max ; Broman, Marcus ; Joannes-Boyau, Olivier ; Ronco, Claudio</creatorcontrib><description>Background/Aims: We assessed how the novel PrisMax continuous renal replacement therapy (CRRT) system performed in an international multicentre setting. The system has multiple novel tools aiming to increase accuracy and dose delivery. Methods: Data was prospectively collected from 7 intensive care units in 6 countries. The PrisMax device data logs constituted the raw material and last generation Prismaflex data was used as comparison. Clinical parameters like treatment time, filter life span, downtime as well as prescribed and delivered dose were recorded. Results: PrisMax delivered/prescribed effluent ratios (mean ± SD) 0.92 ± 0.15 vs. Prismaflex ratios 0.85 ± 0.21, p &lt; 0.001; delivered effluent dose (mL/kg/h) was 18.16 ± 12.93 vs. 10.95 ± 10.96, p &lt; 0.0001; and (Kt/V) 0.76 ± 0.52 vs. 0.44 ± 0.44, p &lt; 0.0001. Moreover, downtime was 27 minutes less for the newer device. Conclusion: The PrisMax CRRT device outperforms its predecessor with regard to dose delivery and accuracy.</description><identifier>ISSN: 0253-5068</identifier><identifier>EISSN: 1421-9735</identifier><identifier>DOI: 10.1159/000494764</identifier><identifier>PMID: 30428467</identifier><language>eng</language><publisher>Basel, Switzerland</publisher><subject>Critical Care Nephrology – Research Article</subject><ispartof>Blood purification, 2019-01, Vol.47 (1-3), p.166-170</ispartof><rights>2018 S. Karger AG, Basel</rights><rights>2018 S. Karger AG, Basel.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-fbd101f6a63fd7169c2505977fb6c5c3c79d8094f6dd6b6d774ffa48c8e5737e3</citedby><orcidid>0000-0003-4320-898X ; 0000-0001-7464-0324 ; 0000-0002-6697-4065</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,2423,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30428467$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:140489003$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Bell, Max</creatorcontrib><creatorcontrib>Broman, Marcus</creatorcontrib><creatorcontrib>Joannes-Boyau, Olivier</creatorcontrib><creatorcontrib>Ronco, Claudio</creatorcontrib><title>Comparison of the Accuracy of the Novel PrisMax Continuous Renal Replacement Therapy System to the Classic Prismaflex System</title><title>Blood purification</title><addtitle>Blood Purif</addtitle><description>Background/Aims: We assessed how the novel PrisMax continuous renal replacement therapy (CRRT) system performed in an international multicentre setting. The system has multiple novel tools aiming to increase accuracy and dose delivery. Methods: Data was prospectively collected from 7 intensive care units in 6 countries. The PrisMax device data logs constituted the raw material and last generation Prismaflex data was used as comparison. Clinical parameters like treatment time, filter life span, downtime as well as prescribed and delivered dose were recorded. Results: PrisMax delivered/prescribed effluent ratios (mean ± SD) 0.92 ± 0.15 vs. Prismaflex ratios 0.85 ± 0.21, p &lt; 0.001; delivered effluent dose (mL/kg/h) was 18.16 ± 12.93 vs. 10.95 ± 10.96, p &lt; 0.0001; and (Kt/V) 0.76 ± 0.52 vs. 0.44 ± 0.44, p &lt; 0.0001. Moreover, downtime was 27 minutes less for the newer device. Conclusion: The PrisMax CRRT device outperforms its predecessor with regard to dose delivery and accuracy.</description><subject>Critical Care Nephrology – Research Article</subject><issn>0253-5068</issn><issn>1421-9735</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNpt0c1P1jAcB_DGYOQRPXg3pAkXPUzb9W07wuJbgkAUzk3X_SqDbR3tpjyJf7yVjefEpW_55PtL80XoDSUfKBXlR0IIL7mS_BnaUJ7TrFRM7KENyQXLBJHFPnoZ4w0hlEtRvkD7jPC84FJt0N_K96MJbfQD9g5P14CPrZ2DsdvH-5n_DR2-SOa7uceVH6Z2mP0c8Q8YTJfWsTMWehgmfHkNwYxb_HMbJ-jx5B8Cqs7E2NqHiN64Du5X8Ao9d6aL8HrdD9DV50-X1dfs9PzLt-r4NLNM5VPm6oYS6qSRzDWKytLmgohSKVdLKyyzqmwKUnInm0bWslGKO2d4YQsQiilgByhbcuMfGOdaj6HtTdhqb1q9Pt2mE2hecMpJ8u8WPwZ_N0OcdN9GC11nBkgf1zllrMgZ43mi7xdqg48xgNuFU6L_l6N35SR7uMbOdQ_NTj62kcDRAm5N-AVhB04urpYIPTYuqbdPqnXKP7mioGM</recordid><startdate>20190101</startdate><enddate>20190101</enddate><creator>Bell, Max</creator><creator>Broman, Marcus</creator><creator>Joannes-Boyau, Olivier</creator><creator>Ronco, Claudio</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>ADTPV</scope><scope>AOWAS</scope><orcidid>https://orcid.org/0000-0003-4320-898X</orcidid><orcidid>https://orcid.org/0000-0001-7464-0324</orcidid><orcidid>https://orcid.org/0000-0002-6697-4065</orcidid></search><sort><creationdate>20190101</creationdate><title>Comparison of the Accuracy of the Novel PrisMax Continuous Renal Replacement Therapy System to the Classic Prismaflex System</title><author>Bell, Max ; Broman, Marcus ; Joannes-Boyau, Olivier ; Ronco, Claudio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-fbd101f6a63fd7169c2505977fb6c5c3c79d8094f6dd6b6d774ffa48c8e5737e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Critical Care Nephrology – Research Article</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bell, Max</creatorcontrib><creatorcontrib>Broman, Marcus</creatorcontrib><creatorcontrib>Joannes-Boyau, Olivier</creatorcontrib><creatorcontrib>Ronco, Claudio</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>SwePub</collection><collection>SwePub Articles</collection><jtitle>Blood purification</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bell, Max</au><au>Broman, Marcus</au><au>Joannes-Boyau, Olivier</au><au>Ronco, Claudio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of the Accuracy of the Novel PrisMax Continuous Renal Replacement Therapy System to the Classic Prismaflex System</atitle><jtitle>Blood purification</jtitle><addtitle>Blood Purif</addtitle><date>2019-01-01</date><risdate>2019</risdate><volume>47</volume><issue>1-3</issue><spage>166</spage><epage>170</epage><pages>166-170</pages><issn>0253-5068</issn><eissn>1421-9735</eissn><abstract>Background/Aims: We assessed how the novel PrisMax continuous renal replacement therapy (CRRT) system performed in an international multicentre setting. The system has multiple novel tools aiming to increase accuracy and dose delivery. Methods: Data was prospectively collected from 7 intensive care units in 6 countries. The PrisMax device data logs constituted the raw material and last generation Prismaflex data was used as comparison. Clinical parameters like treatment time, filter life span, downtime as well as prescribed and delivered dose were recorded. Results: PrisMax delivered/prescribed effluent ratios (mean ± SD) 0.92 ± 0.15 vs. Prismaflex ratios 0.85 ± 0.21, p &lt; 0.001; delivered effluent dose (mL/kg/h) was 18.16 ± 12.93 vs. 10.95 ± 10.96, p &lt; 0.0001; and (Kt/V) 0.76 ± 0.52 vs. 0.44 ± 0.44, p &lt; 0.0001. Moreover, downtime was 27 minutes less for the newer device. Conclusion: The PrisMax CRRT device outperforms its predecessor with regard to dose delivery and accuracy.</abstract><cop>Basel, Switzerland</cop><pmid>30428467</pmid><doi>10.1159/000494764</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0003-4320-898X</orcidid><orcidid>https://orcid.org/0000-0001-7464-0324</orcidid><orcidid>https://orcid.org/0000-0002-6697-4065</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0253-5068
ispartof Blood purification, 2019-01, Vol.47 (1-3), p.166-170
issn 0253-5068
1421-9735
language eng
recordid cdi_karger_primary_494764
source Karger Journals
subjects Critical Care Nephrology – Research Article
title Comparison of the Accuracy of the Novel PrisMax Continuous Renal Replacement Therapy System to the Classic Prismaflex System
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T23%3A17%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_karge&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%20the%20Accuracy%20of%20the%20Novel%20PrisMax%20Continuous%20Renal%20Replacement%20Therapy%20System%20to%20the%20Classic%20Prismaflex%20System&rft.jtitle=Blood%20purification&rft.au=Bell,%20Max&rft.date=2019-01-01&rft.volume=47&rft.issue=1-3&rft.spage=166&rft.epage=170&rft.pages=166-170&rft.issn=0253-5068&rft.eissn=1421-9735&rft_id=info:doi/10.1159/000494764&rft_dat=%3Cproquest_karge%3E2133823342%3C/proquest_karge%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2133823342&rft_id=info:pmid/30428467&rfr_iscdi=true